HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julio García-Suárez Selected Research

Julio García-Suárez Research Topics

Disease

5Neoplasms (Cancer)
11/2021 - 01/2003
3Lymphoma (Lymphomas)
04/2024 - 01/2002
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2023 - 09/2005
3Infections
11/2021 - 01/2003
2Thrombosis (Thrombus)
04/2024 - 01/2016
2COVID-19
01/2024 - 10/2020
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2024 - 11/2021
2Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2020 - 03/2010
2Hematologic Neoplasms (Hematological Malignancy)
10/2020 - 09/2005
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2013 - 01/2007
2Pneumonia (Pneumonitis)
03/2010 - 01/2002
1Multiple Myeloma
04/2024
1Invasive Fungal Infections
11/2021
1Lymphopenia (Lymphocytopenia)
11/2021
1Heart Diseases (Heart Disease)
03/2021
1Confusion (Bewilderment)
03/2021
1Chronic Renal Insufficiency
03/2021
1Sepsis (Septicemia)
01/2016
1Human Influenza (Influenza)
03/2010
1Acute Kidney Injury (Acute Renal Failure)
12/2008
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2005
1Communicable Diseases (Infectious Diseases)
12/2005
1Hodgkin Disease (Hodgkin's Disease)
12/2005
1Progressive Multifocal Leukoencephalopathy
12/2005
1Peritonitis
09/2005
1Chemotherapy-Induced Febrile Neutropenia
01/2003
1Neutropenia
01/2003
1Fever (Fevers)
01/2003
1Hemolysis
06/2002
1Aplastic Anemia (Anemia, Hypoplastic)
01/2002
1Hepatitis
01/2002
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2002

Drug/Important Bio-Agent (IBA)

4Rituximab (Mabthera)FDA Link
11/2021 - 12/2005
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2013 - 01/2002
2Dexamethasone (Maxidex)FDA LinkGeneric
04/2024 - 02/2013
2Monoclonal AntibodiesIBA
11/2021 - 10/2020
2Antineoplastic Agents (Antineoplastics)IBA
10/2020 - 12/2005
2Prednisone (Sone)FDA LinkGeneric
02/2013 - 01/2007
2Vincristine (Oncovin)FDA LinkGeneric
02/2013 - 01/2007
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2013 - 01/2007
2Etoposide (VP 16)FDA LinkGeneric
02/2013 - 01/2007
1Factor VIII (Coagulation Factor VIII)IBA
04/2024
1Protein SIBA
04/2024
1fibrin fragment D (D-dimer)IBA
04/2024
1Biomarkers (Surrogate Marker)IBA
04/2024
1factor V LeidenIBA
04/2024
1Factor XIII (Coagulation Factor XIII)IBA
04/2024
1nirmatrelvir and ritonavir drug combinationIBA
01/2024
1N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2024
1remdesivirIBA
01/2024
1N-(2-cyanoethylene)urea (BA 1)IBA
01/2024
1acalabrutinibIBA
11/2021
1ofatumumabFDA Link
11/2021
1obinutuzumabIBA
11/2021
1ibrutinibIBA
11/2021
1idelalisibIBA
11/2021
1venetoclaxIBA
11/2021
1pembrolizumabIBA
11/2021
1NivolumabIBA
11/2021
1Urea (Carbamide)FDA LinkGeneric
03/2021
1Antiviral Agents (Antivirals)IBA
10/2020
1Methotrexate (Mexate)FDA LinkGeneric
12/2008
1purineIBA
12/2005
1Alkylating AgentsIBA
12/2005
1Anti-Bacterial Agents (Antibiotics)IBA
06/2002
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2002
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2002

Therapy/Procedure

7Drug Therapy (Chemotherapy)
05/2023 - 01/2003
6Therapeutics
10/2020 - 06/2002
1Stem Cell Transplantation
01/2024
1Catheters
01/2016
1Radiotherapy
12/2005
1Organ Transplantation
09/2005
1Continuous Ambulatory Peritoneal Dialysis (CAPD)
09/2005
1Induction Chemotherapy
06/2002
1Aftercare (After-Treatment)
01/2002